BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10812743)

  • 1. More partnerships to spur vaccine development.
    Bull World Health Organ; 2000; 78(3):407. PubMed ID: 10812743
    [No Abstract]   [Full Text] [Related]  

  • 2. Weighing HIV vaccine trials.
    Science; 1994 Aug; 265(5173):735. PubMed ID: 8047878
    [No Abstract]   [Full Text] [Related]  

  • 3. The need for private-public partnerships.
    Nat Med; 2000 May; 6(5):481. PubMed ID: 10802675
    [No Abstract]   [Full Text] [Related]  

  • 4. NIAID collaborates with VaxGen on vaccine studies.
    AIDS Patient Care STDS; 1998 Nov; 12(11):874. PubMed ID: 11362049
    [No Abstract]   [Full Text] [Related]  

  • 5. Ex-UN AIDS chief is blasted for remarks on vaccine strategy.
    Wadman M
    Nature; 1998 Apr; 392(6676):527-8. PubMed ID: 9560133
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccine development moves to front burner.
    AIDS Alert; 1997 Mar; 12(3):32-3. PubMed ID: 11364191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tapping the potential of government-industry collaboration.
    Petricciani JC; Gage P
    Biologicals; 1996 Sep; 24(3):149-55. PubMed ID: 8978912
    [No Abstract]   [Full Text] [Related]  

  • 8. NIAID and Merck to collaborate on HIV vaccine development.
    AIDS Read; 2002 Feb; 12(2):60. PubMed ID: 11905140
    [No Abstract]   [Full Text] [Related]  

  • 9. High-powered support for AIDS vaccine.
    Vogel G
    Science; 1997 Feb; 275(5303):1055. PubMed ID: 9054003
    [No Abstract]   [Full Text] [Related]  

  • 10. NIAID funds center for HIV/AIDS vaccine immunology.
    AIDS Policy Law; 2005 Jul; 20(14):2. PubMed ID: 16108120
    [No Abstract]   [Full Text] [Related]  

  • 11. AlphaVax receives NIAID contract to support development of HIV vaccine.
    Expert Rev Vaccines; 2003 Dec; 2(6):731-2. PubMed ID: 15282844
    [No Abstract]   [Full Text] [Related]  

  • 12. NIH institute to work with trial of AIDS vaccine, despite concerns.
    Wadman M
    Nature; 1998 Aug; 394(6696):818. PubMed ID: 9732856
    [No Abstract]   [Full Text] [Related]  

  • 13. Virtual vaccine centre for HIV/AIDS.
    Nat Rev Microbiol; 2005 Sep; 3(9):673. PubMed ID: 16145754
    [No Abstract]   [Full Text] [Related]  

  • 14. A deadline for an AIDS vaccine.
    Lawler A; Cohen J
    Science; 1997 May; 276(5316):1184-5. PubMed ID: 9182323
    [No Abstract]   [Full Text] [Related]  

  • 15. NIH appoints a director for its AIDS vaccine center.
    Birmingham K
    Nat Med; 1999 Apr; 5(4):362. PubMed ID: 10202909
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccine centres unite specialists in the battle against infectious diseases.
    Gershon D
    Nature; 2000 Dec; 408(6813):753-4. PubMed ID: 11130080
    [No Abstract]   [Full Text] [Related]  

  • 17. Betting big on an AIDS vaccine.
    Nat Med; 2005 Jun; 11(6):579. PubMed ID: 15937450
    [No Abstract]   [Full Text] [Related]  

  • 18. NIH revamps HIV vaccine trials unit.
    Wickware P
    Nat Med; 2000 May; 6(5):488. PubMed ID: 10802685
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines.
    Robinson HL; Weinhold KJ
    J Infect Dis; 2006 Dec; 194(12):1625-7. PubMed ID: 17109331
    [No Abstract]   [Full Text] [Related]  

  • 20. DOD to single out MicroGeneSys vaccine.
    Science; 1993 Apr; 260(5104):19. PubMed ID: 8465193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.